Bayesian decision procedures based on logistic regression models for dose-finding studies
Authors:
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 8 (3) , 445-467
Abstract
Early-phase clinical trials, conducted to determine the appropriate dose of an experimental drug to take forward to later trials, are considered. The objective is to find the dose associated with some low probability of an adverse event. A Bayesian model is presented, and a decision-theoretic procedure for finding the optimal doses for each of a series of cohorts of subjects is derived. The procedure is flexible and can easily be conducted using standard statistical software. The results of simulations investigating the properties of the procedure are presented.Keywords
This publication has 17 references indexed in Scilit:
- IMPROVED DESIGNS FOR DOSE ESCALATION STUDIES USING PHARMACOKINETIC MEASUREMENTSStatistics in Medicine, 1996
- Some practical improvements in the continual reassessment method for phase I studiesStatistics in Medicine, 1995
- BAYESIAN DECISION PROCEDURES FOR DOSE DETERMINING EXPERIMENTSStatistics in Medicine, 1995
- Phase I clinical trials: Adapting methodology to face new challengesAnnals of Oncology, 1994
- Bayesian Theory1994
- Practical modifications of the continual reassessment method for phase i cancer clinical trialsJournal of Biopharmaceutical Statistics, 1994
- The continual reassessment method in cancer phase i clinical trials: A simulation studyStatistics in Medicine, 1993
- Sequential Designs in BioassayBiometrics, 1990
- Design of First-administration Studies in Healthy Man1990
- Experimental Design for Binary DataJournal of the American Statistical Association, 1983